DEAL NOTE: Crowell & Moring Advises Marshall Wace on Series D Investment in InBrace

San Francisco—September 15, 2021: On September 8, 2021, InBrace, a dental company focused on teeth straightening, announced the closing of an oversubscribed $102 million Series D financing. Crowell & Moring represented co-lead investor Marshall Wace, a global alternative investment manager, in the transaction.  InBrace intends to use proceeds of the Series D financing to accelerate growth by expanding its sales force, launching new marketing initiatives, and driving further support and integration with new and existing orthodontic providers across the country.

The financing was co-led by Farallon Capital Management. Additional new investors included funds and accounts managed by BlackRock, Endeavour Vision, MVM Partners, RTW Investments, LP, and Soleus Capital Management, L.P. as well as funds affiliated with existing investors Vivo Capital, Novo Ventures, and venBio. The deal was led by Jon O’Connell with contributions from John Fuson, Anne Li, Steve Ryan, and Justin Lurie.